Animal funds

Apiam Animal Health Limited (AHX.AX) announces a capital increase via a rights offering

Apiam Animal Health Limited

Apiam Animal Health Limited (AHX.AX) Announces Fund Raising Via Rights Offering – Overview

Bendigo, Australia, May 26, 2022 – (ABN Newswire) – Apiam Animal Health Limited (ASX: AHX) is pleased to announce the launch of a 1 for 4.8 pro rata non-cancellation right offering to eligible shareholders (rights offering), to raise $20.25 million before fees. New fully paid common shares (New Rights Shares) to be issued pursuant to the Rights Offering will be offered at $0.70 per share (Offer Price). The offering price represents a 9.1% discount to the last traded price of $0.77 for the Company’s shares on May 25, 2022, and a 10.6% discount to the weighted average based on volume (VWAP) over 5 days of $0.783 for shares of the Company, for the period ending May 25, 2022.

Dr Chris Richards, Managing Director of Apiam, said: “We continue to advance our accelerated growth strategy and last week announced the acquisitions of Victorian Equine Group and Romsey Veterinary Surgery. We have also identified additional strategic opportunities in other fast-growing regional veterinary markets.”

“The funds raised through the rights offering will help us pursue our strategy to double our revenue base to more than $300 million by FY24 and execute the next phase of growth opportunities that we have identified”.

Shaw and Partners Limited (ACN 003 221 583) (Shaws) and Morgans Corporate Limited (ACN 010 539 607) (Morgans), have been appointed joint bookrunners and exclusive underwriters to the rights offering. The Company, Shaws and Morgans have entered into an underwriting agreement (the Underwriting Agreement), pursuant to which Shaws and Morgans (each an underwriter and together the underwriters) will be fully liable for any deficiency in the retail (the Retail Rights Offering) or the institutional component (the Institutional Rights Offering) of the Rights Offering.

Apiam’s chief executive has agreed to take an entitlement of approximately $4.5 million under the entitlement offering.

To view the terms of the agreement, please visit:
https://abnnewswire.net/lnk/23N554V1

To view the fundraising presentation, please visit:
https://www.abnnewswire.net/lnk/617785ZM

About Apiam Animal Health Limited:

Apiam Animal Health Limited (ASX: AHX) comprises Australia’s leading veterinary practices for production animals and mixed animals.

Apiam Animal Health comprises over 150 highly experienced, industry-leading veterinarians with expertise in the swine, dairy, feedlot, sheep, poultry, horse and pet sectors, supported by an experienced administration, nursing, technical services and support team.

Apiam Animal Health is fully vertically integrated, including veterinary wholesale, diagnostic laboratories, custom vaccines, logistics and other ancillary services.

Contact:

Dr Chris Richards
General director
Apiam Animal Health Limited
Email: [email protected]

Catherine Ross
Investor Relations
Email: [email protected]
T: 0421 997 481

Source:
Apiam Animal Health Limited

Copyright (C) 2022 ABN Newswire. All rights reserved.